| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Clinical Research Unit for Gastrointestinal Endocrinology, University of Marburg, Marburg, Hessen, Germany
2 Institute of Pathology, University of Marburg, Marburg, Hessen, Germany
3 Institute of Medical Biometry and Epidemology, University of Marburg, Marburg, Hessen, Germany
* To whom correspondence should be addressed. E-mail: rgoeke{at}gmx.net.
We show that the recently discovered tumor suppressor pdcd4 represses the transcription of the mitosis promoting factor CDK1/cdc2 via upregulation of p21Waf1/Cip1. p21Waf1/Cip1 inhibits CDK4/6 and CDK2. Decrease of CDK4/6 and CDK2 enhances the binding of pRb to E2F/DP which in turn together bind to and repress the cdc2 promoter. Previously, upregulation of CDK1/cdc2 accompanied by a malignant change was reported in colon cancer. We show that expression of pdcd4 as an indirect suppressor of CDK1/cdc2 is lost in progressed carcinomas of lung, breast, colon and prostate. Furthermore, it seems that localization and expression of pdcd4 directly correlates with tumor progression. Finally, the CDK1/cdc2 inhibitor roscovitine reduced the proliferation of several tumor cell lines suggesting that inhibition of CDK1/cdc2 may be a useful strategy against malignant transformation. Therefore, pdcd4 might serve as a novel target for antineoplastic therapies.
This article has been cited by other articles:
|
|
 |
|
  A. Miyanaga, A. Gemma, R. Noro, K. Kataoka, K. Matsuda, M. Nara, T. Okano, M. Seike, A. Yoshimura, A. Kawakami, et al. Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model Mol. Cancer Ther., July 1, 2008; 7(7): 1923 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ozpolat, U. Akar, M. Steiner, I. Zorrilla-Calancha, M. Tirado-Gomez, N. Colburn, M. Danilenko, S. Kornblau, and G. Lopez Berestein Programmed Cell Death-4 Tumor Suppressor Protein Contributes to Retinoic Acid-Induced Terminal Granulocytic Differentiation of Human Myeloid Leukemia Cells Mol. Cancer Res., January 1, 2007; 5(1): 95 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jin, T. H. Kim, S.-K. Hwang, S.-H. Chang, H. W. Kim, H. K. Anderson, H.-W. Lee, K.-H. Lee, N. H. Colburn, H.-S. Yang, et al. Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol. Cancer Ther., April 1, 2006; 5(4): 1041 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Palamarchuk, A. Efanov, V. Maximov, R. I. Aqeilan, C. M. Croce, and Y. Pekarsky Akt Phosphorylates and Regulates Pdcd4 Tumor Suppressor Protein Cancer Res., December 15, 2005; 65(24): 11282 - 11286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Jansen, C. E. Camalier, and N. H. Colburn Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis Cancer Res., July 15, 2005; 65(14): 6034 - 6041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. ZAKOWICZ, H.-S. YANG, C. STARK, A. WLODAWER, N. LARONDE-LEBLANC, and N. H. COLBURN Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI RNA, March 1, 2005; 11(3): 261 - 274. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
